on stone activity is not well studied. Our goal was to determine if SI CaOx correlates with stone activity in calcium oxalate (CaOx) stone formers.
INTRODUCTION AND OBJECTIVES: NSAIDs should be considered first line for the management of renal colic. Despite numerous RCTs supporting their use in clinical practice, NSAIDs are often inconsistently used in patients with renal colic in the emergency department (ED). We examined the use of NSAIDs and effects on outcomes in patients with renal colic and those with ureteral stones who presented to the ED.
METHODS: A retrospective analysis was conducted on all consecutive patients with an ICD-9 diagnosis of kidney calculus (592.00), ureteral calculus (592.1), and renal colic (788.0) who presented to our ED between October 2011 and August 2013. We only included patients that presented to the ED then were discharged. For our secondary analysis we only included patients with a confirmed ureteral stone based on imaging.
RESULTS: A total of 330 patients were available for analysis. NSAIDs were the first choice in 49.1% (162/330) of patients and was utilized in 67.1% (221/330) of patients. Those given NSAIDs first were significantly less likely to need additional pain medications than those given narcotics first (p¼0.006). When performing a subgroup analysis of patients returning to the ED within 30 days, NSAIDs were used significantly less at discharge (47.6% vs 24%, p¼0.015) while there was no difference in narcotic prescriptions. Furthermore, we repeated the analysis for patients returning to the ED within 30 days with a confirmed ureteral stone on imaging and found a significantly less rate of NSAID use at discharge in those that returned (53% vs 17.7%, p¼0.006). No other factor was predictive of a return visit to the ED.
CONCLUSIONS: Despite clear evidence towards the use of NSAIDs in the acute setting for renal colic, variability still exists in the way ED practitioners prescribe these medications. NSAID use may contribute to less need for additional pain medications and may decrease early return visits (within 30 days) to the ED. 
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INTRODUCTION AND OBJECTIVES:
A majority of patients with acute renal colic are discharged from the emergency department (ED) after initial diagnosis and symptom management. Unfortunately 20-30% of these patients require repeat ED visit for ongoing symptom control and 15%-25% require urgent urological intervention. If these patients destined for outpatient failure could be identified prior to discharge, they may benefit from early intervention to reduce morbidity as well as reduce health care expenditure of a repeat ED visit. Our objective was to identify predictors of outpatient treatment failure, defined as the need for hospitalization or urgent intervention within 60 days of ED discharge.
METHODS: Prospectively gathered administrative data from 4 hospitals in Calgary, Alberta, Canada of patients with an ED diagnosis of renal colic from January 1st, 2014 to December 31st, 2014 was collected. Imaging reports were reviewed for stone characteristics. Data was linked to regional hospital databases to identify ED revisits, hospital admissions and surgical procedures. Patients were excluded if they were non-residents of Calgary or if they had a previous renal colic visit within 30 days.
RESULTS: Of 3104 patients with first ED visit for acute renal colic, 1081 were discharged without intervention for a trial of spontaneous passage. Median patient age was 50 and 72% were males. As per table 1, on multivariate analysis we demonstrate the only predictor for outpatient treatment failure was proximal and mid-ureteric stone location. We found no association between gender, degree of hydronephrosis or stone size.
CONCLUSIONS: Using a prospectively gathered database we demonstrate patients with stones in their proximal or mid ureter are almost 3 times as likely to require 60-day hospital readmission or urgent intervention. Our results demonstrate treatment options should be considered for these patients prior to discharge. 197, No. 4S, Supplement, Tuesday, May 16, 2017 
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